Dublin, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/gk23nq/molecular) has announced the addition of the "Molecular Diagnostic Testing for Infectious Diseases Global Market Size, Strategies and Forecasts 2016 to 2020 " report to their offering.
The Molecular Diagnostics - Infectious Disease sector of the clinical diagnostics industry is poised for record growth. A market that just keeps on growing. Infectious disease testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. Learn all about it in this new report. A range of dynamic trends are pushing market growth and company valuations.
Trends like:
- changing demographics
- emerging economies and global prosperity
- biotechnology advances in genetics
- pathogen evolution
- climate change
- globalization
- automation
Exciting technical developments especially in the area of molecular diagnostics and pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.
The report has hundreds of pages of information including a complete list of Current 2016 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions. Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth.
The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
This research makes you the expert in your organization.
All report data is available in Excel format on request.
Make investment decisions and valuations with confidence using the latest data.
Key Topics Covered:
1. Introduction and Market Definition
2. The Infectious Diseases - Market Analysis by Disease
3. Industry Overview
4. Market Trends
5. Molecular Dx - Infectious Disease Recent Developments
6. Country Market Sizes - North America
7. Country Markets - Europe
8. Country Markets - Asia Pacific
9. Country Markets - Latin America, Africa & The Middle East
10. Global Market Summary
Companies Mentioned
- Abbott Laboratories
- Agendia
- Agilent/Dako
- Becton, Dickinson & Co.
- bioMérieux
- Cepheid
- Foundation Medicine
- Genomic Health
- Grifols
- Hologic
- Illumina
- Myriad Genetics
- Qiagen
- Roche Molecular Diagnostics
- Siemens Healthcare
- Signal Genetics LLC
- Thermo Fisher
For more information visit http://www.researchandmarkets.com/research/gk23nq/molecular
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics, In Vitro Diagnostics, Infectious Disease Testing, Molecular Diagnostics


Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia 



